Home » Prices » NASDAQ:NSTG

NanoString Technologies, Inc. stock price

Today's NASDAQ:NSTG chart, history & news

Price:
57.07 USD
Change:
+0.56 (0.99%)
Key Stats
Price open 56.71
Previous close 56.51
Market cap 2.51B
Volume 627.76K
Day high
Day low
Year high 57.07
Year low 16.01
Year to date change 106.13%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About NanoString Technologies, Inc.

NanoString Technologies, Inc. is a publicly held biotech company that specializes in development of cancer diagnostics tools. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. The company was founded by Krassen Dimitrov, Amber Ratcliffe, and Dwayne Dunaway in 2003, and is based in Seattle, Washington. NanoString's "nCounter Analysis System" is based on a digital molecular barcoding technology invented by Dimitrov and Dunawa[citation needed] in Leroy Hood's lab at the Institute for Systems Biology , and became commercially available in 2008. NanoString received a CE-mark designation for selling the Prosigna breast cancer prognostic gene signature assay in Israel and EU in September 2012, and in September 2013, NanoString received FDA 510 clearance for Prosigna. NanoString's nCounter technology is a variation on the DNA microarray and was invented and patented by Krassen Dimitrov and Dwayne Dunaway.[citation needed] It uses molecular "barcodes" and microscopic imaging to detect and count up to several hundred unique transcripts in one hybridization reaction.

Company information

Company name
Nanostring Technologies Inc
Exchange
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Employees
270
CEO
R. Bradley Gray
Address
530 Fairview Ave N, Seattle, Washington, 98109-5553
Country
United States
Contact information
12063786266
Website
https://www.nanostring.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.